J, S., XM, K., C, M., N, N., D, P., S, S., . . . E, K. (2018). 68-Gallium DOTATATE scanning in symptomatic patients with negative anatomic imaging but suspected neuroendocrine tumor. International journal of endocrine oncology, 5(1), IJE04. https://doi.org/10.2217/ije-2017-0005
Chicago Style (17th ed.) CitationJ, Shell, et al. "68-Gallium DOTATATE Scanning in Symptomatic Patients with Negative Anatomic Imaging but Suspected Neuroendocrine Tumor." International Journal of Endocrine Oncology 5, no. 1 (2018): IJE04. https://doi.org/10.2217/ije-2017-0005.
MLA (9th ed.) CitationJ, Shell, et al. "68-Gallium DOTATATE Scanning in Symptomatic Patients with Negative Anatomic Imaging but Suspected Neuroendocrine Tumor." International Journal of Endocrine Oncology, vol. 5, no. 1, 2018, p. IJE04, https://doi.org/10.2217/ije-2017-0005.